"Let's Stay Together"; GIP and GLP-1 dual agonism in the treatment of metabolic disease

被引:6
作者
DiMarchi, Richard D. [1 ,2 ]
机构
[1] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA
[2] Novo Nordisk, Bagsvaerd, Denmark
来源
MOLECULAR METABOLISM | 2018年 / 18卷
关键词
D O I
10.1016/j.molmet.2018.10.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1 / 2
页数:2
相关论文
共 10 条
[1]  
Campbell J, 2013, CELL METAB, V17, P1
[2]   LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept [J].
Coskun, Tamer ;
Sloop, Kyle W. ;
Loghin, Corina ;
Alsina-Fernandez, Jorge ;
Urva, Shweta ;
Bokvist, Krister B. ;
Cui, Xuewei ;
Briere, Daniel A. ;
Cabrera, Over ;
Roell, William C. ;
Kuchibhotla, Uma ;
Moyers, Julie S. ;
Benson, Charles T. ;
Gimeno, Ruth E. ;
D'Alessio, David A. ;
Haupt, Axel .
MOLECULAR METABOLISM, 2018, 18 :3-14
[3]   Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists Specifically Optimized for Multidose Formulations [J].
Evers, Andreas ;
Bossart, Martin ;
Pfeiffer-Marek, Stefania ;
Elvert, Ralf ;
Schreuder, Herman ;
Kurz, Michael ;
Stengelin, Siegfried ;
Lorenz, Martin ;
Herling, Andreas ;
Konkar, Anish ;
Lukasczyk, Ulrike ;
Pfenninger, Anja ;
Lorenz, Katrin ;
Haack, Torsten ;
Kadereit, Dieter ;
Wagner, Michael .
JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (13) :5580-5593
[4]   Reappraisal of GIP Pharmacology for Metabolic Diseases [J].
Finan, Brian ;
Mueller, Timo D. ;
Clemmensen, Christoffer ;
Perez-Tilve, Diego ;
DiMarchi, Richard D. ;
Tschoep, Matthias H. .
TRENDS IN MOLECULAR MEDICINE, 2016, 22 (05) :359-376
[5]   A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents [J].
Finan, Brian ;
Yang, Bin ;
Ottaway, Nickki ;
Smiley, David L. ;
Ma, Tao ;
Clemmensen, Christoffer ;
Chabenne, Joe ;
Zhang, Lianshan ;
Habegger, Kirk M. ;
Fischer, Katrin ;
Campbell, Jonathan E. ;
Sandoval, Dar Leen ;
Seeley, Randy J. ;
Bleicher, Konrad ;
Uhles, Sabine ;
Riboulet, William ;
Funk, Jurgen ;
Hertel, Cornelia ;
Belli, Sara ;
Sebokova, Elena ;
Conde-Knape, Karin ;
Konkar, Anish ;
Drucker, Daniel J. ;
Gelfanov, Vasily ;
Pfluger, Paul T. ;
Muller, Timo D. ;
Perez-Tilve, Diego ;
DiMarchi, Richard D. ;
Tschop, Matthias H. .
NATURE MEDICINE, 2015, 21 (01) :27-36
[6]   Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans [J].
Finan, Brian ;
Ma, Tao ;
Ottaway, Nickki ;
Mueller, Timo D. ;
Habegger, Kirk M. ;
Heppner, Kristy M. ;
Kirchner, Henriette ;
Holland, Jenna ;
Hembree, Jazzminn ;
Raver, Christine ;
Lockie, Sarah H. ;
Smiley, David L. ;
Gelfanov, Vasily ;
Yang, Bin ;
Hofmann, Susanna ;
Bruemmer, Dennis ;
Drucker, Daniel J. ;
Pfluger, Paul T. ;
Perez-Tilve, Diego ;
Gidda, Jaswant ;
Vignati, Louis ;
Zhang, Lianshan ;
Hauptman, Jonathan B. ;
Lau, Michele ;
Brecheisen, Mathieu ;
Uhles, Sabine ;
Riboulet, William ;
Hainaut, Emmanuelle ;
Sebokova, Elena ;
Conde-Knape, Karin ;
Konkar, Anish ;
DiMarchi, Richard D. ;
Tschoep, Matthias H. .
SCIENCE TRANSLATIONAL MEDICINE, 2013, 5 (209)
[7]   Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial [J].
Frias, Juan Pablo ;
Nauck, Michael A. ;
Van, Joanna ;
Kutner, Mark E. ;
Cui, Xuewei ;
Benson, Charles ;
Urva, Shweta ;
Gimeno, Ruth E. ;
Milicevic, Zvonko ;
Robins, Deborah ;
Haupt, Axel .
LANCET, 2018, 392 (10160) :2180-2193
[8]   The Sustained Effects of a Dual GIP/GLP-1 Receptor Agonist, NNC0090-2746, in Patients with Type 2 Diabetes [J].
Frias, Juan Pablo ;
Bastyr, Edward J., III ;
Vignati, Louis ;
Tschoep, Matthias H. ;
Schmitt, Christophe ;
Owen, Klara ;
Christensen, Rune Haubo ;
DiMarchi, Richard D. .
CELL METABOLISM, 2017, 26 (02) :343-+
[9]   Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide [J].
Lau, Jesper ;
Bloch, Paw ;
Schaffer, Lauge ;
Pettersson, Ingrid ;
Spetzler, Jane ;
Kofoed, Jacob ;
Madsen, Kjeld ;
Knudsen, Lotte Bjerre ;
McGuire, James ;
Steensgaard, Dorte Bjerre ;
Strauss, Holger Martin ;
Gram, Dorte X. ;
Knudsen, Sanne Moller ;
Nielsen, Flemming Seier ;
Thygesen, Peter ;
Reedtz-Runge, Steffen ;
Kruse, Thomas .
JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (18) :7370-7380
[10]   Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial [J].
Pratley, Richard E. ;
Aroda, Vanita R. ;
Lingvay, Ildiko ;
Luedemann, Jorg ;
Andreassen, Camilla ;
Navarria, Andrea ;
Viljoen, Adie .
LANCET DIABETES & ENDOCRINOLOGY, 2018, 6 (04) :275-286